Use Of Experimental Ebola Vaccine To Begin Soon In DRC Following Government Approval, WHO Says

Associated Press: Congo approves use of experimental Ebola vaccine, WHO says
“Congo has agreed to allow the World Health Organization to use an experimental Ebola vaccine to combat an outbreak announced last week, the WHO director general said Monday. The aim is for health officials to start using the vaccine, once it’s shipped, by the end of the week, or next week if there are difficulties, said WHO Director-General Tedros Adhanom Ghebreyesus…” (Mwanamilongo/Keaten, 5/14).

CIDRAP News: New Ebola cases reported as WHO head visits DRC
“Over the weekend, the Democratic Republic of the Congo (DRC) reported seven more suspected cases of Ebola, raising the totals from Apr 4 through May 13 to 39 confirmed, suspected, and probable cases, including 19 deaths, for a case-fatality rate of 49 percent. Only two cases have been confirmed by laboratory testing, and 25 are probable. The remaining 12 cases are suspected…” (Soucheray, 5/14).

Additional coverage of this story is available from ABC News, Bloomberg, CNN, Reuters, and Washington Post.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.